White Paper

FSP Future View: The Functional Service Provider Model In 2025

By Chris Baker, Senior Vice President, Global Head Parexel FSP

FSP-CLimage

The current Covid-19 crisis is driving R&D innovation in unprecedented ways, casting a glaring light on the need for greater speed, interoperability, and deployment of technologies such as remote data capture and artificial intelligence.

The future of drug development is on our doorstep. In order to be competitive in this new landscape, biopharma must:

  • Rapidly adopt new technologies: remote data capture, artificial intelligence, robotics, machine learning, natural language processing.
  • Integrate technologies into standardized, interoperable systems.
  • Develop talent to implement new trial designs and operational models.

Sponsors must prepare now by embracing the tools and collaborations emerging in biopharma’s digital transformation. The rapid growth of functional service provider (FSP) outsourcing is evidence of the model’s ability to meet the challenge flexibly and cost-effectively. This paper shares Parexel’s view of change drivers, essential infrastructure components, and advancing FSP capabilities over the next five years.

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of ECM Connection? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: